Evidence map›Paper›PMID 41323791›Full record

ArticleJournal of Cancer2025

Comprehensive Bioinformatics Analysis and Validation of the Mechanism of Glutamic-pyruvic Transaminase 2 in Bladder Cancer.

Haonan Dong, Hongqiong Li, Shi Chen, Qun Wang, Yawei Zhang, Hongjin Shi, Jieming Zuo, Junhao Chen, Jiansong Wang, Haifeng Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haonan DongYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Hongqiong LiYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Shi ChenYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Qun WangYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Yawei ZhangYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Hongjin ShiYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Jieming ZuoYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Junhao ChenYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Jiansong WangYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Haifeng WangYunnan Institute of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancerdrug resistanceepithelial-mesenchymal transition (EMT)glutamine metabolism

Identifiers

PMID41323791
PMCPMC12664720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.